Kawasaki Disease Taiwan

Expert Ranking: 1st in Kawasaki disease at Asia.

Expert Ranking: Worldwide

$D:\2013年生技獎照片\DSC_0018.JPG$

2013/10 1^st Kawasaki Disease Center in Taiwan.

Kawasaki disease (KD) is a multisystemic vasculitis of unknown cause that primarily affects children under the age of five (75-80%). KD occurs in every ethnicity and in all corners of the globe, although the highest incidence is reported in Asian countries, particularly Japan, Korea, and Taiwan. The major clinical characteristics of KD are a persistent high-grade fever, bilateral non-purulent conjunctivitis, diffuse mucosal inflammation, polymorphous skin rashes, indurative angioedema of the hands and feet, and non-suppurative cervical lymphadenopathy.

The most serious complications of KD are coronary artery lesions (CAL) such dilation and aneurysm formation that can lead to thrombosis and myocardial infarction. The development of CAL can have serious long-term consequences and may greatly impact the child's life and ability to stay active. As a result of cardiac sequelae, the affected child may also have to take anticoagulant drugs throughout the rest of their lifetime. In 2010, KD was unanimously elected and recognized as the most difficult pediatric disease to diagnose and manage by more than 500 pediatric specialists.

For KD, the goal of our team is to achieve a prognosis of zero mortality. This stems from our aim at comprehensive care with a solid clinical medical training team and improving therapeutic techniques. We have also implemented an attentive tracking service to remain up-to-date with the most recent research, including the genetics of KD. In the last three years, our team has become the global leader in the amount of published research on this disease, and has published the first book on Kawasaki disease to reach bookshelves.

Furthermore, we also offer a rare "without borders" worldwide network of medical services for KD. Our strong clinical healthcare service includes a lineup of eight sub-specialties to treat this systemic disease: neonatology, pediatric infectious disease, pediatric cardiology, gastroenterology, pediatric nephrology, pediatric rheumatology, pediatric pulmonology, and pediatric neurology, in addition to our Department of Nursing and Social Welfare Division, to jointly provide pediatric care for one of the most difficult childhood diseases. Therefore, in reaching the toughest pediatric disease – KD – we are the global leader in comprehensive care.

中文簡介

川崎症是後天性兒童心臟病最常見的原因，他會引起兒童全身性的血管發炎，而最厲害之處是就是造成心臟的血管發炎，因為心臟血管發炎可能會影響孩子一輩子的活動，也可能會影響孩子一輩子都必須要服用抗凝血劑的藥物，對孩童影響極大。這個疾病曾經在2010年的兒科疾病診療困難度進行票選，由500多名的兒科專科醫師點選出了川崎症是兒科醫師一致公認排名第一的最棘手也最難處裡的兒科疾病。

對於川崎症，我們團隊的特色是達到零死亡率的預後，因為我們擁有全面性的照護，扎實的臨床醫療訓練團隊，和極佳的治療品質，更還有體貼的追蹤服務；在基因研究及研究論文數量更已經是領先全球。進一步的，我們還提供全世界少有的無國界的網路醫療服務；除此之外，也還撰寫了第一本針對川崎症的上架書籍。在堅強的臨床醫療照護服務上，我們的陣容包括有八個次專科:新生兒科、兒童感染科、兒童心臟科、兒童腸胃科、兒童腎臟科、兒童風濕免疫科、兒童神經內科、兒童胸腔科護理部與社會福利課共同來服務照護這兒科最棘手的兒童疾病。進而達成兒科最棘手疾病-川崎症的全面性照護並領先全球。

$F:\川崎症整合型計畫\2013整合型計劃合照.jpg$